Search

You searched for "patient"

1088 results found

BBS Revolution™ Bladder Scanner

10 January 2022 | Research & Development
BBS Revolution™ - the next generation bladder scanner delivering the goals of modern healthcare – better outcomes, lower costs, happier patients, and happier providers.

Minze Uroflow System

2 March 2022 | Research & Development
Minze Uroflow System with Bluetooth makes it possible for men, women and children with LUTs and bladder dysfunction to be assessed, diagnosed and monitored remotely in the comfort of their homes.

Bupa covers accurate PSE prostate cancer blood test

9 April 2025 | Contracts & Distributors, Research & Development
A new era in prostate cancer detection is emerging with the EpiSwitch® PSE blood test, a highly accurate tool that enhances early diagnosis while significantly cutting false positives. Now covered by Bupa as a pre-biopsy test, PSE has demonstrated 94%...

Is it time for a kidney stress test?

21 January 2026 | Research & Development, Urology News
In healthcare, what we measure shapes how we predict outcomes and intervene. For kidney health, traditional tools like estimated glomerular filtration rate (eGFR) provide only a partial picture. Relying solely on eGFR is like judging heart health with a resting...

Surgical video – part 1: intraoperative video recording and storage

1 March 2015 | | URO - Technology
The use of digital technology has progressed in leaps and bounds and nowhere is this more apparent than in medicine and surgery. Footage of live surgery is now easily accessed on the internet or displayed at conferences. Thus, the 21st...

Demanding cases or nightmares in uro-oncology? Sep/Oct 2022

5 September 2022 | | URO - Urologic Oncology
Treatment of prostate cancer in renal transplant recipients is challenging due to a lack of knowledge of the natural history of cancer in these patients, the anatomical position of the graft in the iliac fossa and its proximity to the...

Benign prostatic hyperplasia: what are the benefits and harms of various surgical management options?

9 March 2020 | | URO - Functional / Reconstructive Urology, URO - Infection, URO - Neurourology, URO - Technology
Benign prostatic hyperplasia (BPH) is characterised by stromal and epithelial prostatic cell hyperplasia. The enlarged prostate may be associated with voiding and storage lower urinary tract symptoms (LUTS). These have been predominantly attributed to bladder outlet obstruction (BOO), assumed to...

Management of RHC in prostate cancer with selective embolisation and hyperbaric oxygen therapy

4 July 2024 | | URO - Urologic Oncology
Prostate cancer is one of the most prevalent malignancies affecting men worldwide. Radiotherapy is a common treatment modality for localised and locally advanced prostate cancer. While radiotherapy can be effective, it may lead to complications such as radiation-induced haemorrhagic cystitis...

ICS (International Continence Society) 2024

23 October 2024 -25 October 2024
Each year, the International Continence Society hosts its annual meeting bringing together healthcare professionals interested in treating incontinence patients. Attendees can benefit from the latest research, professional development and networking opportunities. It provides a platform to exchange ideas and share best practices. Leading experts in the field also present workshops and state of the art sessions.

ICS -EUS (International Continence Society and the Emirates Urological Society) Annual Meeting 2025

17 September 2025 -20 September 2025
A special joint Annual Meeting of the International Continence Society and the Emirates Urological Society, taking place in vibrant Abu Dhabi in 2025. Inviting healthcare professionals from around the world interested in treating incontinence patients. Attendees can benefit from the...

Recent advances in the management of castration resistant prostate cancer

1 November 2017 | | URO - Urologic Oncology
Castrate resistant prostate cancer (CRPC) is defined by disease progression despite androgen-deprivation therapy lowering testosterone to castrate levels. It may present as a rise in serum levels of prostate specific antigen (PSA), progression of pre-existing disease, or the appearance of...

History of prostate biopsy – part 2

1 September 2018 | | URO - Basic Science Research, URO - Urologic Oncology, URO - Technology
For Part 1 of this topic is available here. The major limitations of the transrectal ultrasound (TRUS) guided prostate biopsy (PBx) protocols are the risk of profound sepsis and the risk of persistently significant false negative rates, related to the...